Use of Myo-inositol as Adjuvant Therapy in Patients With Polycystic Ovary Syndrome (PCOS) in Vitro Fertilization (IVF)

Inclusion Criteria: * Patients PCOS (Rotterdam ESHRE / ASRM criteria) Combination of at least two of the following three criteria: * Cycle disorder * Clinical hyperandrogenism and / or biological * Account antral follicles\> 24 * Age ≤ 18 ≤ 38 years * BMI \<35 kg / m² * Able to understand the protocol and signed informed consent Exclusion Criteria: * Patients not having the Rotterdam criteria * Patients\> 38 years and / or BMI\> 35 kg / m² * Woman enjoying a measure of legal protection * Hypersensitivity to any component of the Inofolic (myo-inositol, soy, folic acid, glycerol, gelatin, coloring E171) * Participation in another interventional biomedical research with treatment administered may disrupt ovarian stimulation